Evidence for the role of corticotropin-releasing factor in major depressive disorder

Neuroscience and Biobehavioral Reviews

Volumn 58, Issue , 2015, Pages 63-78

  Waters, R Parrish ^a   Rivalan, Marion ^b   Bangasser, D A ^c   Deussing, J M ^d   Ising, M ^d   Wood, S K ^e   Holsboer, F ^d,f   Summers, Cliff H ^g,h  

^a UNIVERSITY OF MARY WASHINGTON   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TEMPLE UNIVERSITY   (United States)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f HMNC GmbH   (Germany)

^g UNIVERSITY OF SOUTH DAKOTA   (United States)

^h UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

CRF; CRF1; Depression; Stress

Indexed keywords

BIOLOGICAL MARKER; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROTRANSMITTER; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ANXIETY DISORDER; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; INTRACELLULAR SIGNALING; MAJOR DEPRESSION; MENTAL STRESS; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIAL STRESS; GENETICS; METABOLISM;

CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; HUMANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84949502446     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.07.011     Document Type: Review

References (261)

1. Aguilera G., Millan M.A., Hauger R.L., Catt K.J. Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues. Ann. N. Y. Acad. Sci. 1987, 512:48-66.
2. Ahnaou A., Steckler T., Heylen A., Kennis L., Nakazato A., Chaki S., Drinkenburg W.H. R278995/cra0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: implication for therapeutic indication. Eur. J. Pharmacol. 2012, 680:63-68.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, 5th ed., 10.1176/appi.books.9780890425596.744053.
4. Anacker C. Adult hippocampal neurogenesis in depression: behavioral implications and regulation by the stress system. Curr. Top. Behav. Neurosci. 2014.
5. Arendt D.H., Hassell J., Li H., Achua J.K., Guarnieri D.J., Dileone R.J., Ronan P.J., Summers C.H. Anxiolytic function of the orexin 2/hypocretin a receptor in the basolateral amygdala. Psychoneuroendocrinology 2014, 40:17-26.
6. Austin M.C., Janosky J.E., Murphy H.A. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol. Psychiatry 2003, 8:324-332.
7. Bale T., Vale W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
8. Bale T.L., Vale W.W. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 2003, 23:5295-5301.
9. Bangasser D.A. Sex differences in stress-related receptors: "micro" differences with "macro" implications for mood and anxiety disorders. Biol. Sex Differ. 2013, 4:2.
10. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., Van Bockstaele E.J., Valentino R.J. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 2010, 15(877):896-904.
11. Bangasser D.A., Reyes B.A., Piel D., Garachh V., Zhang X.Y., Plona Z.M., Van Bockstaele E.J., Beck S.G., Valentino R.J. Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol. Psychiatry 2013, 18:166-173.
12. Bangasser D.A., Valentino R.J. Sex differences in molecular and cellular substrates of stress. Cell. Mol. Neurobiol. 2012, 32:709-723.
13. Bangasser D.A., Valentino R.J. Sex differences in stress-related psychiatric disorders: neurobiological perspectives. Front. Neuroendocrinol. 2014, 35:303-319.
14. Banki C.M., Bissette G., Arato M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry 1987, 144:873-877.
15. Banki C.M., Karmacsi L., Bissette G., Nemeroff C.B. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur. Neuropsychopharmacol. 1992, 2:107-113.
16. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol. Psychiatry 2008, 13:1079-1092.
17. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., Vale W.W. Corticotropin releasing factor (CRF) binding protein: a novel regulator of crf and related peptides. Front. Neuroendocrinol. 1995, 16:362-382.
18. Behan D.P., Maciejewski D., Chalmers D., De Souza E.B. Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res. 1995, 698:259-264.
19. Bennett M.R., Lagopoulos J. Stress and trauma: BDNF control of dendritic-spine formation and regression. Prog. Neurobiol. 2014, 112:80-99.
20. Berridge C.W., Dunn A.J. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul. Pept. 1986, 16:83-93.
21. Berridge C.W., Dunn A.J. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm. Behav. 1987, 21:393-401.
22. Bhatnagar S., Vining C., Iyer V., Kinni V. Changes in hypothalamic-pituitary-adrenal function, body temperature, body weight and food intake with repeated social stress exposure in rats. J. Neuroendocrinol. 2006, 18:13-24.
23. Billings A.G., Moos R.H. Coping, stress, and social resources among adults with unipolar depression. J. Pers. Soc. Psychol. 1984, 46:877-891.
24. Binder E.B., Nemeroff C.B. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 2010, 15:574-588.
25. Bissette G., Klimek V., Pan J., Stockmeier C., Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 2003, 28:1328-1335.
26. Bittencourt J.C., Sawchenko P.E. Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J. Neurosci. 2000, 20:1142-1156.
27. Bittencourt J.C., Vaughan J., Arias C., Rissman R.A., Vale W.W., Sawchenko P.E. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 1999, 415:285-312.
28. Bjorkqvist K. Social defeat as a stressor in humans. Physiol. Behav. 2001, 73:435-442.
29. Boorse G.C., Denver R.J. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen. Comp. Endocrinol. 2006, 146:9-18.
30. Britton D.R., Koob G.F., Rivier J., Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 1982, 31:363-367.
31. Britton K.T., Lee G., Dana R., Risch S.C., Koob G.F. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 1986, 39:1281-1286.
32. Britton K.T., Lee G., Vale W., Rivier J., Koob G.F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 1986, 369:303-306.
33. Brown M.R., Fisher L.A., Spiess J., Rivier C., Rivier J., Vale W. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982, 111:928-931.
34. Buwalda B., de Boer S.F., Schmidt E.D., Felszeghy K., Nyakas C., Sgoifo A., Van der Vegt B.J., Tilders F.J., Bohus B., Koolhaas J.M. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J. Neuroendocrinol. 1999, 11:513-520.
35. Camp N.J., Lowry M.R., Richards R.L., Plenk A.M., Carter C., Hensel C.H., Abkevich V., Skolnick M.H., Shattuck D., Rowe K.G., Hughes D.C., Cannon-Albright L.A. Genome-wide linkage analyses of extended utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 135B:85-93.
36. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-htt gene. Science 2003, 301:386-389.
37. Catt K.J., Millan M.A., Wynn P.C., Mendelsohn F.A., Aguilera G. Brain receptors for hypothalamic hormones. Adv. Biochem. Psychopharmacol. 1987, 43:51-67.
38. 1 receptor antagonist, r278995/cra0450. Eur. J. Pharmacol. 2004, 485:145-158.
39. 1 receptor mRNA expression. J. Neurosci. 1995, 15:6340-6350.
40. Chen A., Zorrilla E., Smith S., Rousso D., Levy C., Vaughan J., Donaldson C., Roberts A., Lee K.F., Vale W. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 2006, 26:5500-5510.
41. Chen Y., Bender R.A., Frotscher M., Baram T.Z. Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J. Neurosci. 2001, 21:7171-7181.
42. Choi D., Furay A., Evanson N., Ostrander M., Ulrich-Lai Y., Herman J. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J. Neurosci. 2007, 27:2025-2034.
43. Choi D.C., Evanson N.K., Furay A.R., Ulrich-Lai Y.M., Ostrander M.M., Herman J.P. The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitary-adrenocortical axis responses to acute and chronic stress. Endocrinology 2008, 149:818-826.
44. Collins P.Y., Patel V., Joestl S.S., March D., Insel T.R., Daar A.S., Scientific Advisory B., the Executive Committee of the Grand Challenges on Global Mental H., Anderson W., Dhansay M.A., Phillips A., Shurin S., Walport M., Ewart W., Savill S.J., Bordin I.A., Costello E.J., Durkin M., Fairburn C., Glass R.I., Hall W., Huang Y., Hyman S.E., Jamison K., Kaaya S., Kapur S., Kleinman A., Ogunniyi A., Otero-Ojeda A., Poo M.M., Ravindranath V., Sahakian B.J., Saxena S., Singer P.A., Stein D.J. Grand challenges in global mental health. Nature 2011, 475:27-30.
45. Commons K.G., Connolley K.R., Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 2003, 28:206-215.
46. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W., Gold L.H. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res. 1999, 835:1-9.
47. Cummings S., Elde R., Ells J., Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 1983, 3:1355-1368.
48. Curtis A.L., Bethea T., Valentino R.J. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 2006, 31:544-554.
49. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 2002, 23:71-77.
50. 1 receptor desensitization. Biochem. Biophys. Res. Commun. 2002, 298:303-308.
51. De Bellis M.D., Gold P.W., Geracioti T.D., Listwak S.J., Kling M.A. Association of fluoxetine treatment with reductions in csf concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am. J. Psychiatry 1993, 150:656-657.
52. Dedic N., Touma C., Romanowski C.P., Schieven M., Kuhne C., Ableitner M., Lu A., Holsboer F., Wurst W., Kimura M., Deussing J.M. Assessing behavioural effects of chronic hpa axis activation using conditional crh-overexpressing mice. Cell. Mol. Neurobiol. 2012, 32:815-828.
53. Deussing J.M., Breu J., Kühne C., Kallnik M., Bunck M., Glasl L., Yen Y.C., Schmidt M.V., Zurmühlen R., Vogl A.M., Gailus-Durner V., Fuchs H., Hölter S.M., Wotjak C.T., Landgraf R., de Angelis M.H., Holsboer F., Wurst W. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J. Neurosci. 2010, 27:9103-9116.
54. DeWire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 2007, 69:483-510.
55. Dirks A., Groenink L., Bouwknecht J.A., Hijzen T.H., Van Der Gugten J., Ronken E., Verbeek J.S., Veening J.G., Dederen P.J., Korosi A., Schoolderman L.F., Roubos E.W., Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur. J. Neurosci. 2002, 16:1751-1760.
56. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology 1996, 137:2167-2170.
57. Duman R.S. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress. Anxiety 2014, 31:291-296.
58. Dunn A., Swiergiel A. Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann. N. Y. Acad. Sci. 2008, 1148:118-126.
59. Dunn A.J., Berridge C.W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol. Biochem. Behav. 1987, 27:685-691.
60. Dunn A.J., Berridge C.W. Is corticotropin-releasing factor a mediator of stress responses?. Ann. N. Y. Acad. Sci. 1990, 579:183-191.
61. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Brain Res. Rev. 1990, 15:71-100.
62. Elliott E., Ezra-Nevo G., Regev L., Neufeld-Cohen A., Chen A. Resilience to social stress coincides with functional DNA methylation of the CRF gene in adult mice. Nat. Neurosci. 2010, 13:1351-1353.
63. Fisher L.A., Rivier J., Rivier C., Spiess J., Vale W., Brown M.R. Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982, 110:2222-2224.
64. Flandreau E.I., Ressler K.J., Owens M.J., Nemeroff C.B. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces hpa axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 2012, 37:27-38.
65. Folkman S., Lazarus R.S. An analysis of coping in a middle-aged community sample. J. Health Soc. Behav. 1980, 21:219-239.
66. Galard R., Catalan R., Castellanos J.M., Gallart J.M. Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test. Biol. Psychiatry 2002, 51:463-468.
67. Gold P.W., Chrousos G.P. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc. Assoc. Am. Physicians 1999, 111:22-34.
68. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low crh/ne states. Mol. Psychiatry 2002, 7:254-275.
69. Goldstein B.L., Klein D.N. A review of selected candidate endophenotypes for depression. Clin. Psychol. Rev. 2014, 34:417-427.
70. Grammatopoulos D.K., Dai Y., Randeva H.S., Levine M.A., Karteris E., Easton A.J., Hillhouse E.W. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol. Endocrinol. 1999, 13:2189-2202.
71. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., Hillhouse E.W. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple g proteins. J. Neurochem. 2001, 76:509-519.
72. Griebel G., Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nat. Rev. Drug Discov. 2012, 11:462-478.
73. Griebel G., Simiand J., Steinberg R., Jung M., Gully D., Roger P., Geslin M., Scatton B., Maffrand J.P., Soubrie P. 4-(2-Chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylp henyl)ethyl]5-methyl-n-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (ssr 125543a), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J. Pharmacol. Exp. Therap. 2002, 301:333-345.
74. Gu J., Sadler L., Daiger S., Wells D., Wagner M. Dinucleotide repeat polymorphism at the crh gene. Hum. Mol. Genet. 1993, 2:85.
75. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., Watkins L.R., Maier S.F. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 2003, 23:1019-1025.
76. Hammen C. Stress and depression. Ann. Rev. Clin. Psychol. 2005, 1:293-319. in or out?
77. Hamon M., Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Progr. Neuropsychopharmacol. Biol. Psychiatry 2013, 54-63.
78. Harkness K.L., Theriault J.E., Stewart J.G., Bagby R.M. Acute and chronic stress exposure predicts 1-year recurrence in adult outpatients with residual depression symptoms following response to treatment. Depress. Anxiety 2014, 31:1-8.
79. Hartline K.M., Owens M.J., Nemeroff C.B. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans. Ann. N. Y. Acad. Sci. 1996, 780:96-105.
80. Hashimoto K., Nishiyama M., Tanaka Y., Noguchi T., Asaba K., Hossein P.N., Nishioka T., Makino S. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Peptides 2004, 25:1711-1721.
81. Hauger R.L., Grigoriadis D.E., Dallman M.F., Plotsky P.M., Vale W.W., Dautzenberg F.M. International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 2003, 55:21-26.
82. Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 2006, 5:453-479.
83. Hauger R.L., Risbrough V., Oakley R.H., Olivares-Reyes J.A., Dautzenberg F.M. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N. Y. Acad. Sci. 2009, 1179:120-143.
84. Hauger R.L., Smith R.D., Braun S., Dautzenberg F.M., Catt K.J. Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. Biochem. Biophys. Res. Commun. 2000, 268:572-576.
85. Heinrichs S.C., Menzaghi F., Merlo Pich E., Britton K.T., Koob G.F. The role of CRF in behavioral aspects of stress. Ann. N. Y. Acad. Sci. 1995, 92-104.
86. Heitland I., Groenink L., Bijlsma E.Y., Oosting R.S., Baas J.M. Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter. PLOS ONE 2013, 8:e63772.
87. Held K., Kunzel H., Ising M., Schmid D.A., Zobel A., Murck H., Holsboer F., Steiger A. Treatment with the crh1-receptor-antagonist r121919 improves sleep-eeg in patients with depression. J. Psychiatr. Res. 2004, 38:129-136.
88. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997, 20:78-84.
89. Herringa R.J., Roseboom P.H., Kalin N.H. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects. Neuropsychopharmacology 2006, 31:1822-1831.
90. Heuser I., Bissette G., Dettling M., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Nemeroff C.B., Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety 1998, 8:71-79.
91. Hillhouse E.W., Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 2006, 27:260-286.
92. Hiroi N., Wong M.L., Licinio J., Park C., Young M., Gold P.W., Chrousos G.P., Bornstein S.R. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol. Psychiatry 2001, 6:540-546.
93. Hirschfeld R.M. Depression epidemiology and its treatment evolution. J. Clin. Psychiatry 2012, 73:e29.
94. Holmes K.D., Babwah A.V., Dale L.B., Poulter M.O., Ferguson S.S. Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and rab gtpases. J. Neurochem. 2006, 96:934-949.
95. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
96. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 2010, 61:81-109. C101-111.
97. Hosang G.M., Shiles C., Tansey K.E., McGuffin P., Uher R. Interaction between stress and the bdnf val66met polymorphism in depression: a systematic review and meta-analysis. BMC Med. 2014, 12:7.
98. Howerton A.R., Roland A.V., Fluharty J.M., Marshall A., Chen A., Daniels D., Beck S.G., Bale T.L. Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity. Biol. Psychiatry 2014, 75:873-883.
99. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7:605-611.
100. Huising M.O., Flik G. The remarkable conservation of corticotropin-releasing hormone (crh)-binding protein in the honeybee (apis mellifera) dates the crh system to a common ancestor of insects and vertebrates. Endocrinology 2005, 146:2165-2170.
101. Iniguez S.D., Riggs L.M., Nieto S.J., Dayrit G., Zamora N.N., Shawhan K.L., Cruz B., Warren B.L. Social defeat stress induces a depression-like phenotype in adolescent male c57bl/6 mice. Stress 2014, 17:247-255.
102. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/crh test as a potential surrogate marker in depression. Progr. Neuro-psychopharmacol. Biol. Psychiatry 2005, 29:1085-1093.
103. 1 receptor antagonist nbi-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology 2007, 32:1941-1949.
104. Jha S., Dong B., Sakata K. Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV. Transl. Psychiatry 2011, 1:e40.
105. Ju G., Han Z.S. Coexistence of corticotropin releasing factor and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat. Neurosci. Lett. 1989, 99(3):246-250.
106. Ju G., Swanson L.W. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. Cytoarchitecture. J. Comp. Neurol. 1989, 280(4):587-602.
107. Jutkiewicz E.M., Wood S.K., Houshyar H., Hsin L.W., Rice K.C., Woods J.H. The effects of CRF antagonists, antalarmin, cp154,526, lwh234, and r121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology (Berlin) 2005, 180:215-223.
108. Kageyama K., Bradbury M.J., Zhao L., Blount A.L., Vale W.W. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 1999, 140:5651-5658.
109. Keck M.E. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 2006, 31:241-250.
110. Keck M.E., Kern N., Erhardt A., Unschuld P.G., Ising M., Salyakina D., Muller M.B., Knorr C.C., Lieb R., Hohoff C., Krakowitzky P., Maier W., Bandelow B., Fritze J., Deckert J., Holsboer F., Muller-Myhsok B., Binder E.B. Combined effects of exonic polymorphisms in crhr1 and avpr1b genes in a case/control study for panic disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1196-1204.
111. Kelly E., Bailey C.P., Henderson G. Agonist-selective mechanisms of gpcr desensitization. Br. J. Pharmacol. 2008, 153(Suppl. 1):S379-S388.
112. Kelsoe J.R., Spence M.A., Loetscher E., Foguet M., Sadovnick A.D., Remick R.A., Flodman P., Khristich J., Mroczkowski-Parker Z., Brown J.L., Masser D., Ungerleider S., Rapaport M.H., Wishart W.L., Luebbert H. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:585-590.
113. Kessler R.C. Epidemiology of women and depression. J. Affect. Disord. 2003, 74:5-13.
114. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the national comorbidity survey. I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 1993, 29:85-96.
115. Kimura M., Muller-Preuss P., Lu A., Wiesner E., Flachskamm C., Wurst W., Holsboer F., Deussing J.M. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol. Psychiatry 2010, 15:154-165.
116. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., Beck S.G. Corticotropin-releasing factor increases gaba synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 2008, 28:12927-12937.
117. Kirby L.G., Rice K.C., Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000, 22:148-162.
118. Kleiman E.M., Liu R.T., Riskind J.H., Hamilton J.L. Depression as a mediator of negative cognitive style and hopelessness in stress generation. Br. J. Psychol. 2014.
119. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
120. Kohout T.A., Lefkowitz R.J. Regulation of g protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 2003, 63:9-18.
121. Kolber B.J., Boyle M.P., Wieczorek L., Kelley C.L., Onwuzurike C.C., Nettles S.A., Vogt S.K., Muglia L.J. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice. J. Neurosci. 2010, 30:2571-2581.
122. Koob G.F., Heinrichs S.C., Pich E.M., Menzaghi F., Baldwin H., Miczek K., Britton K.T. The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found. Symp. 1993, 172:277-289. discussion 290-5.
123. Koolhaas J.M., De Boer S.F., De Rutter A.J., Meerlo P., Sgoifo A. Social stress in rats and mice. Acta Physiol. Scand. Suppl. 1997, 640:69-72.
124. Koolhaas J.M., Korte S.M., De Boer S.F., Van Der Vegt B.J., Van Reenen C.G., Hopster H., De Jong I.C., Ruis M.A., Blokhuis H.J. Coping styles in animals: current status in behavior and stress-physiology. Neurosci. Biobehav. Rev. 1999, 23:925-935.
125. Kovacs M., Lengvari I., Liposits Z., Vigh S., Schally A.V., Flerko B. Corticotropin-releasing factor (CRF)-immunoreactive neurons in the mammillary body of the rat. Cell Tissue Res. 1985, 240:455-460.
126. Krasel C., Bunemann M., Lorenz K., Lohse M.J. Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J. Biol. Chem. 2005, 280:9528-9535.
127. Krieger D.T., Liotta A., Brownstein M.J. Corticotropin releasing factor distribution in normal and brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals. Endocrinology 1977, 100:227-237.
128. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
129. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 894-902.
130. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2010, 1305-1320.
131. Krishnan V., Nestler E.J. Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 2011, 7:121-147.
132. Kruijt A.W., Putman P., Van der Does W. The 5-httlpr polymorphism, early and recent life stress, and cognitive endophenotypes of depression. Cognit. Emot. 2014, 28:1149-1163.
133. Laryea G., Arnett M.G., Muglia L.J. Behavioral studies and genetic alterations in corticotropin-releasing hormone (crh) neurocircuitry: insights into human psychiatric disorders. Behav. Sci. 2012, 2:135-171.
134. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
135. Lemos J.C., Wanat M.J., Smith J.S., Reyes B.A., Hollon N.G., Van Bockstaele E.J., Chavkin C., Phillips P.E. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 2012, 490:402-406.
136. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7570-7575.
137. Licinio J., O'Kirwan F., Irizarry K., Merriman B., Thakur S., Jepson R., Lake S., Tantisira K.G., Weiss S.T., Wong M.L. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in mexican-americans. Mol. Psychiatry 2004, 9:1075-1082.
138. Lim M.M., Nair H.P., Young L.J. Species and sex differences in brain distribution of corticotropin-releasing factor receptor subtypes 1 and 2 in monogamous and promiscuous vole species. J. Compar. Neurol. 2005, 487:75-92.
139. Liu J., Juo S.H., Dewan A., Grunn A., Tong X., Brito M., Park N., Loth J.E., Kanyas K., Lerer B., Endicott J., Penchaszadeh G., Knowles J.A., Ott J., Gilliam T.C., Baron M. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol. Psychiatry 2003, 8:333-342.
140. Liu Z., Zhu F., Wang G., Xiao Z., Wang H., Tang J., Wang X., Qiu D., Liu W., Cao Z., Li W. Association of corticotropin-releasing hormone receptor1 gene snp and haplotype with major depression. Neurosci. Lett. 2006, 404:358-362.
141. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995, 136:4139-4142.
142. Lu A., Steiner M.A., Whittle N., Vogl A.M., Walser S.M., Ableitner M., Refojo D., Ekker M., Rubenstein J.L., Stalla G.K., Singewald N., Holsboer F., Wotjak C.T., Wurst W., Deussing J.M. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol. Psychiatry 2008, 13:1028-1042.
143. Mahar I., Bambico F.R., Mechawar N., Nobrega J.N. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci. Biobehav. Rev. 2014, 38:173-192.
144. Marcheco-Teruel B., Flint T.J., Wikman F.P., Torralbas M., Gonzalez L., Blanco L., Tan Q., Ewald H., Orntoft T., Kruse T.A., Borglum A.D., Mors O. A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of cuba. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B:833-843.
145. Marcus M., Yasami T., van Ommeren M., Chisholm D. Depression: A Global Public Health Concern 2014, World Health Organization. http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf?ua=1.
146. Markovic D., Punn A., Lehnert H., Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 2008, 22:689-706.
147. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
148. McFadden K., Griffin T.A., Levy V., Wolfe J.H., Valentino R.J. Overexpression of corticotropin-releasing factor in barrington's nucleus neurons by adeno-associated viral transduction: effects on bladder function and behavior. Eur. J. Neurosci. 2012, 36:3356-3364.
149. McQueen M.B., Devlin B., Faraone S.V., Nimgaonkar V.L., Sklar P., Smoller J.W., Abou Jamra R., Albus M., Bacanu S.A., Baron M., Barrett T.B., Berrettini W., Blacker D., Byerley W., Cichon S., Coryell W., Craddock N., Daly M.J., Depaulo J.R., Edenberg H.J., Foroud T., Gill M., Gilliam T.C., Hamshere M., Jones I., Jones L., Juo S.H., Kelsoe J.R., Lambert D., Lange C., Lerer B., Liu J., Maier W., Mackinnon J.D., McInnis M.G., McMahon F.J., Murphy D.L., Nothen M.M., Nurnberger J.I., Pato C.N., Pato M.T., Potash J.B., Propping P., Pulver A.E., Rice J.P., Rietschel M., Scheftner W., Schumacher J., Segurado R., Van Steen K., Xie W., Zandi P.P., Laird N.M. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am. J. Hum. Genet. 2005, 77:582-595.
150. Meerlo P., Sgoifo A., De Boer S.F., Koolhaas J.M. Long-lasting consequences of a social conflict in rats: behavior during the interaction predicts subsequent changes in daily rhythms of heart rate, temperature, and activity. Behav. Neurosci. 1999, 113:1283-1290.
151. Mehta D., Raison C.L., Woolwine B.J., Haroon E., Binder E.B., Miller A.H., Felger J.C. Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav. Immun. 2013, 31:205-215.
152. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and gaba(a) receptor subunits in frontal cortical brain region. J. Neurosci. 2004, 24:1478-1485.
153. Merali Z., Kent P., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Bedard T., Anisman H. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin b alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 2006, 59:594-602.
154. Miczek K.A. A new test for aggression in rats without aversive stimulation: differential effects of d-amphetamine and cocaine. Psychopharmacology (Berlin) 1979, 60:253-259.
155. Millan M.A., Jacobowitz D.M., Hauger R.L., Catt K.J., Aguilera G. Distribution of corticotropin-releasing factor receptors in primate brain. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:1921-1925.
156. Miller B.R., Hen R. The current state of the neurogenic theory of depression and anxiety. Curr. Opin. Neurobiol. 2014, 30C:51-58.
157. Moga M.M., Saper C.B., Gray T.S. Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J. Comp. Neurol. 1989, 283(3):315-332.
158. Monroe S.M., Slavich G.M., Gotlib I.H. Life stress and family history for depression: the moderating role of past depressive episodes. J. Psychiatr. Res. 2014, 49:90-95.
159. Moore C.A., Milano S.K., Benovic J.L. Regulation of receptor trafficking by grks and arrestins. Annu. Rev. Physiol. 2007, 69:451-482.
160. Morris M.C., Rao U., Wang L., Garber J. Cortisol reactivity to experimentally manipulated psychosocial stress in young adults at varied risk for depression. Depress. Anxiety 2014, 31:44-52.
161. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995, 373:427-432.
162. Mulinari S. Monoamine theories of depression: historical impact on biomedical research. J. Hist. Neurosci. 2012, 21:366-392.
163. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., Kormann M.S., Droste S.K., Kuhn R., Reul J.M., Holsboer F., Wurst W. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 2003, 6:1100-1107.
164. Nederhof E., Ormel J., Oldehinkel A.J. Mismatch or cumulative stress: the pathway to depression is conditional on attention style. Psychol. Sci. 2014, 25:684-692.
165. Nemeroff C.B. The neurobiology of depression. Sci. Am. 1998, 278:42-49.
166. Nemeroff C.B., Bissette G., Akil H., Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Br. J. Psychiatry 1991, 158:59-63.
167. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of csf corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
168. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
169. Nielsen D.M., Carey G.J., Gold L.H. Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice. Eur. J. Pharmacol. 2004, 499:135-146.
170. Nolen-Hoeksema S., Larson J., Grayson C. Explaining the gender difference in depressive symptoms. J. Pers. Soc. Psychol. 1999, 77:1061-1072.
171. 1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses. Am. J. Physiol. Regul. Integr. Compar. Physiol. 2007, 293:R209-R222.
172. Olschowka J.A., O'Donohue T.L., Mueller G.P., Jacobowitz D.M. The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain. Peptides 1982, 3:995-1015.
173. Overstreet D.H., Friedman E., Mathe A.A., Yadid G. The flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 2005, 29:739-759.
174. Papiol S., Arias B., Gasto C., Gutierrez B., Catalan R., Fananas L. Genetic variability at hpa axis in major depression and clinical response to antidepressant treatment. J. Affect. Disord. 2007, 104:83-90.
175. Paull W.K., Phelix C.F., Copeland M., Palmiter P., Gibbs F.P., Middleton C. Immunohistochemical localization of corticotropin releasing factor (CRF) in the hypothalamus of the squirrel monkey, saimiri sciureus. Peptides 1984, 5(Suppl. 1):45-51.
176. Paull W.K., Scholer J., Arimura A., Meyers C.A., Chang J.K., Chang D., Shimizu M. Immunocytochemical localization of CRF in the ovine hypothalamus. Peptides 1982, 3:183-191.
177. Paykel E.S. Life events and affective disorders. Acta Psychiatr. Scand. Suppl. 2003, 61-66.
178. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 1999, 885:312-328.
179. Pezawas L., Meyer-Lindenberg A., Goldman A.L., Verchinski B.A., Chen G., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. Evidence of biologic epistasis between bdnf and slc6a4 and implications for depression. Mol. Psychiatry 2008, 13:709-716.
180. Plante D.T., Landsness E.C., Peterson M.J., Goldstein M.R., Riedner B.A., Wanger T., Guokas J.J., Tononi G., Benca R.M. Sex-related differences in sleep slow wave activity in major depressive disorder: a high-density eeg investigation. BMC Psychiatry 2012, 12:146.
181. van den Pol A.N. Neuropeptide transmission in brain circuits. Neuron 2012, 76:98-115.
182. Polter A.M., Kauer J.A. Stress and vta synapses: implications for addiction and depression. Eur. J. Neurosci. 2014, 39:1179-1188.
183. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., Vale W.W. Cloning and characterization of the cdnas for human and rat corticotropin releasing factor-binding proteins. Nature 1991, 349:423-426.
184. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:4192-4196.
185. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8777-8781.
186. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 1998, 18:492-502.
187. Qi X., Shan Z., Ji Y., Guerra V., Alexander J.C., Ormerod B.K., Bruijnzeel A.W. Sustained aav-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal. Transl. Psychiatry 2014, 4:e385.
188. Raadsheer F.C., Tilders F.J., Swaab D.F. Similar age related increase of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and alzheimer patients. J. Neuroendocrinol. 1994, 6:131-133.
189. Refojo D., Schweizer M., Kuehne C., Ehrenberg S., Thoeringer C., Vogl A.M., Dedic N., Schumacher M., von Wolff G., Avrabos C., Touma C., Engblom D., Schutz G., Nave K.A., Eder M., Wotjak C.T., Sillaber I., Holsboer F., Wurst W., Deussing J.M. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of crhr1. Science 2011, 333:1903-1907.
190. Regev L., Neufeld-Cohen A., Tsoory M., Kuperman Y., Getselter D., Gil S., Chen A. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol. Psychiatry 2011, 16:714-728.
191. Regev L., Tsoory M., Gil S., Chen A. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge. Biol. Psychiatry 2012, 71:317-326.
192. Ressler K.J., Bradley B., Mercer K.B., Deveau T.C., Smith A.K., Gillespie C.F., Nemeroff C.B., Cubells J.F., Binder E.B. Polymorphisms in crhr1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2010, 153B:812-824.
193. Reyes B., Fox K., Valentino R., Van Bockstaele E. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur. J. Neurosci. 2006, 23:2991-2998.
194. Reyes B., Valentino R., Van Bockstaele E. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008, 149:122-130.
195. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2843-2848.
196. Roche M., Commons K.G., Peoples A., Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 2003, 23:970-977.
197. Ronan P.J., Summers C.H. Molecular signaling and translational significance of the corticotropin releasing factor system. Progr. Mol. Biol. Transl. Sci. 2011, 98:235-292.
198. Rosmond R., Chagnon M., Bouchard C., Bjorntorp P. A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene-gene interaction. Metabolism 2001, 50:1059-1062.
199. Ryabinin A.E., Tsivkovskaia N.O., Ryabinin S.A. Urocortin 1-containing neurons in the human edinger-westphal nucleus. Neuroscience 2005, 134:1317-1323.
200. Rybnikova E.A., Pelto-Huikko M., Rakitskaya V.V., Shalyapina V.G. Localization of corticoliberin receptors in the rat brain. Neurosci. Behav. Physiol. 2003, 33:399-404.
201. Rygula R., Abumaria N., Flugge G., Fuchs E., Ruther E., Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav. Brain Res. 2005, 162:127-134.
202. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., Olive M.F. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berlin) 2006, 186:122-132.
203. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986, 382:213-238.
204. Sakanaka M., Shibasaki T., Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J. Compar. Neurol. 1987, 260:256-298.
205. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57:925-935.
206. Saravanan C., Wilks R. Medical students' experience of and reaction to stress: the role of depression and anxiety. Sci. World J. 2014, 2014:737382.
207. Seasholtz A.F., Valverde R.A., Denver R.J. Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J. Endocrinol. 2002, 175:89-97.
208. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., Ekholm J., Cichon S., Turecki G., Claes S., Kelsoe J.R., Schofield P.R., Badenhop R.F., Morissette J., Coon H., Blackwood D., McInnes L.A., Foroud T., Edenberg H.J., Reich T., Rice J.P., Goate A., McInnis M.G., McMahon F.J., Badner J.A., Goldin L.R., Bennett P., Willour V.L., Zandi P.P., Liu J., Gilliam C., Juo S.H., Berrettini W.H., Yoshikawa T., Peltonen L., Lonnqvist J., Nothen M.M., Schumacher J., Windemuth C., Rietschel M., Propping P., Maier W., Alda M., Grof P., Rouleau G.A., Del-Favero J., Van Broeckhoven C., Mendlewicz J., Adolfsson R., Spence M.A., Luebbert H., Adams L.J., Donald J.A., Mitchell P.B., Barden N., Shink E., Byerley W., Muir W., Visscher P.M., Macgregor S., Gurling H., Kalsi G., McQuillin A., Escamilla M.A., Reus V.I., Leon P., Freimer N.B., Ewald H., Kruse T.A., Mors O., Radhakrishna U., Blouin J.L., Antonarakis S.E., Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part III: Bipolar disorder. Am. J. Hum. Genet. 2003, 73:49-62.
209. Sgoifo A., Koolhaas J.M., Musso E., De Boer S.F. Different sympathovagal modulation of heart rate during social and nonsocial stress episodes in wild-type rats. Physiol. Behav. 1999, 67:733-738.
210. Sgoifo A., Pozzato C., Meerlo P., Costoli T., Manghi M., Stilli D., Olivetti G., Musso E. Intermittent exposure to social defeat and open-field test in rats: acute and long-term effects on ecg, body temperature and physical activity. Stress 2002, 5:23-35.
211. Shapero B.G., Black S.K., Liu R.T., Klugman J., Bender R.E., Abramson L.Y., Alloy L.B. Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity. J. Clin. Psychol. 2014, 70:209-223.
212. Sheng H., Sun T., Cong B., He P., Zhang Y., Yan J., Lu C., Ni X. Corticotropin-releasing hormone stimulates sgk-1 kinase expression in cultured hippocampal neurons via crh-r1. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E938-E946.
213. Sickmann H.M., Li Y., Mork A., Sanchez C., Gulinello M. Does stress elicit depression? Evidence from clinical and preclinical studies. Curr. Top. Behav. Neurosci. 2014.
214. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
215. Smoller J.W., Rosenbaum J.F., Biederman J., Kennedy J., Dai D., Racette S.R., Laird N.M., Kagan J., Snidman N., Hirshfeld-Becker D., Tsuang M.T., Sklar P.B., Slaugenhaupt S.A. Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol. Psychiatry 2003, 54:1376-1381.
216. Smoller J.W., Yamaki L.H., Fagerness J.A., Biederman J., Racette S., Laird N.M., Kagan J., Snidman N., Faraone S.V., Hirshfeld-Becker D., Tsuang M.T., Slaugenhaupt S.A., Rosenbaum J.F., Sklar P.B. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol. Psychiatry 2005, 57:1485-1492.
217. Snyder K., Wang W.W., Han R., McFadden K., Valentino R.J. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. Neuropsychopharmacology 2012, 37:520-530.
218. Steiger A. Sleep and endocrinology. J. Intern. Med. 2003, 254:13-22.
219. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 1994, 14:2579-2584.
220. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982, 297:331-333.
221. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005, 4:141-194.
222. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
223. Swerdlow N.R., Geyer M.A., Vale W.W., Koob G.F. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berlin) 1986, 88:147-152.
224. Tanaka M., Telegdy G. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice. Brain Res. Bull. 2008, 75:509-512.
225. Taniguchi H., He M., Wu P., Kim S., Paik R., Sugino K., Kvitsiani D., Fu Y., Lu J., Lin Y., Miyoshi G., Shima Y., Fishell G., Nelson S.B., Huang Z.J. A resource of cre driver lines for genetic targeting of gabaergic neurons in cerebral cortex. Neuron 2011, 71:995-1013.
226. Teli T., Markovic D., Levine M.A., Hillhouse E.W., Grammatopoulos D.K. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for g protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol. Endocrinol. 2005, 19:474-490.
227. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 1998, 19:162-166.
228. Tornatzky W., Miczek K.A. Long-term impairment of autonomic circadian rhythms after brief intermittent social stress. Physiol. Behav. 1993, 53:983-993.
229. Valdez G.R. CRF receptors as a potential target in the development of novel pharmacotherapies for depression. Curr. Pharm. Des. 2009, 15:1587-1594.
230. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
231. Valentino R.J., Bangasser D., Van Bockstaele E.J. Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model. Mol. Pharmacol. 2013, 83:737-745.
232. Valentino R.J., Commons K.G. Peptides that fine tune the serotonin system. Neuropeptides 2005, 39:1-8.
233. Valentino R.J., Van Bockstaele E., Bangasser D. Sex-specific cell signaling: the corticotropin-releasing factor receptor model. Trends Pharmacol. Sci. 2013, 34:437-444.
234. Valentino R.J., Van Bockstaele E.J. Chapter 4.4 - functional interactions between stress neuromediators and the locus coeruleus-norepinephrine system. Techniques in the Behavioral and Neural Sciences 2005, 465-486. Elsevier. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
235. Valentino R.J., Wood S.K., Wein A.J., Zderic S.A. The bladder-brain connection: putative role of corticotropin-releasing factor. Nat. Rev. Urol. 2011, 8:19-28.
236. Veith R.C., Lewis N., Langohr J.I., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R., Pascualy M., Bissette G., Nemeroff C.B., et al. Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiatry Res. 1993, 46:1-8.
237. Vicentini E., Arban R., Angelici O., Maraia G., Perico M., Mugnaini M., Ugolini A., Large C., Domenici E., Gerrard P., Bortner D., Mansuy I.M., Mangiarini L., Merlo-Pich E. Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice. Pharmacol. Biochem. Behav. 2009, 93:17-24.
238. Vigod S.N., Stewart D.E. Emergent research in the cause of mental illness in women across the lifespan. Curr. Opin. Psychiatry 2009, 22:396-400.
239. Vinkers C.H., Joels M., Milaneschi Y., Kahn R.S., Penninx B.W., Boks M.P. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depress. Anxiety 2014, 31:737-745.
240. Vitoratos N., Papatheodorou D.C., Kalantaridou S.N., Mastorakos G. "Reproductive" corticotropin-releasing hormone. Ann. N. Y. Acad. Sci. 2006, 1092:310-318.
241. Walker D., Miles L., Davis M. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33:1291-1308.
242. Walsh J.J., Friedman A.K., Sun H., Heller E.A., Ku S.M., Juarez B., Burnham V.L., Mazei-Robison M.S., Ferguson D., Golden S.A., Koo J.W., Chaudhury D., Christoffel D.J., Pomeranz L., Friedman J.M., Russo S.J., Nestler E.J., Han M.H. Stress and CRF gate neural activation of bdnf in the mesolimbic reward pathway. Nat. Neurosci. 2014, 17:27-29.
243. Wang X.D., Chen Y., Wolf M., Wagner K.V., Liebl C., Scharf S.H., Harbich D., Mayer B., Wurst W., Holsboer F., Deussing J.M., Baram T.Z., Muller M.B., Schmidt M.V. Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiol. Dis. 2011, 42:300-310.
244. Wang X.D., Labermaier C., Holsboer F., Wurst W., Deussing J.M., Muller M.B., Schmidt M.V. Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. Eur. J. Neurosci. 2012, 36:2360-2367.
245. Wang X.D., Rammes G., Kraev I., Wolf M., Liebl C., Scharf S.H., Rice C.J., Wurst W., Holsboer F., Deussing J.M., Baram T.Z., Stewart M.G., Muller M.B., Schmidt M.V. Forebrain CRF(1) modulates early-life stress-programmed cognitive deficits. J. Neurosci. 2011, 31:13625-13634.
246. Waselus M., Nazzaro C., Valentino R.J., Van Bockstaele E.J. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. BPS 2009, 76-83.
247. Wasserman D., Sokolowski M., Rozanov V., Wasserman J. The crhr1 gene: a marker for suicidality in depressed males exposed to low stress. Genes Brain Behav. 2008, 7:14-19.
248. Weathington J.M., Hamki A., Cooke B.M. Sex- and region-specific pubertal maturation of the corticotropin-releasing factor receptor system in the rat. J. Compar. Neurol. 2014, 522:1284-1298.
249. Webster E.L., Lewis D.B., Torpy D.J., Zachman E.K., Rice K.C., Chrousos G.P. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (crh) receptor antagonist: suppression of pituitary acth release and peripheral inflammation. Endocrinology 1996, 137:5747-5750.
250. Weitemier A.Z., Tsivkovskaia N.O., Ryabinin A.E. Urocortin 1 distribution in mouse brain is strain-dependent. Neuroscience 2005, 132:729-740.
251. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., Berridge C.W., Majzoub J.A. Stress-induced behaviors require the corticotropin-releasing hormone (crh) receptor, but not crh. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8283-8288.
252. Wong M.L., al-Shekhlee A., Bongiorno P.B., Esposito A., Khatri P., Sternberg E.M., Gold P.W., Licinio J. Localization of urocortin messenger rna in rat brain and pituitary. Mol. Psychiatry 1996, 1:307-312.
253. Wood S.K., McFadden K., Griffin T., Wolfe J.H., Zderic S., Valentino R.J. A corticotropin-releasing factor receptor antagonist improves urodynamic dysfunction produced by social stress or partial bladder outlet obstruction in male rats. Am. J. Physiol. Regul. Integr. Compar. Physiol. 2013, 304:R940-R950.
254. Wood S.K., McFadden K.V., Grigoriadis D., Bhatnagar S., Valentino R.J. Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor. Psychopharmacology (Berlin) 2012, 325-336.
255. Wood S.K., Walker H.E., Valentino R.J., Bhatnagar S. Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology 2010, 1795-1805.
256. Wood S.K., Wood C.S., Lombard C.M., Lee C.S., Zhang X.-Y., Finnell J.E., Valentino R.J. Inflammatory factors mediate vulnerability to a social stress-induced depressive-like phenotype in passive coping rats. Biol. Psychiatry 2015, 78:38-48.
257. Wood S.K., Zhang X.Y., Reyes B.A., Lee C.S., Van Bockstaele E.J., Valentino R.J. Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress. Biol. Psychiatry 2013, 73:1087-1094.
258. Wust S., Kumsta R., Treutlein J., Frank J., Entringer S., Schulze T.G., Rietschel M. Sex-specific association between the 5-htt gene-linked polymorphic region and basal cortisol secretion. Psychoneuroendocrinology 2009, 34:972-982.
259. Yamano M., Yuki H., Yasuda S., Miyata K. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha ym643-induced depression-like behavior in mice. J. Pharmacol. Exp. Therap. 2000, 292:181-187.
260. Yu H., Wang D.D., Wang Y., Liu T., Lee F.S., Chen Z.Y. Variant brain-derived neurotrophic factor val66met polymorphism alters vulnerability to stress and response to antidepressants. J. Neurosci. 2012, 32:4092-4101.
261. 1 receptor in CRF signaling. Acta Biochim. Pol. 2010, 57:1-13.